Intuitive Surgical, Inc. (0R29.L)
USD 527.02
(-3.15%)
USD 527.02
(-3.15%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15.44 Billion USD | 19.02% |
| 2022 | 12.97 Billion USD | -4.29% |
| 2021 | 13.55 Billion USD | 21.36% |
| 2020 | 11.16 Billion USD | 14.75% |
| 2019 | 9.73 Billion USD | 24.04% |
| 2018 | 7.84 Billion USD | 36.27% |
| 2017 | 5.75 Billion USD | -11.24% |
| 2016 | 6.48 Billion USD | 32.19% |
| 2015 | 4.9 Billion USD | 23.94% |
| 2014 | 3.95 Billion USD | 0.23% |
| 2013 | 3.95 Billion USD | -2.68% |
| 2012 | 4.05 Billion USD | 32.52% |
| 2011 | 3.06 Billion USD | 28.14% |
| 2010 | 2.39 Billion USD | 32.09% |
| 2009 | 1.8 Billion USD | 22.72% |
| 2008 | 1.47 Billion USD | 41.79% |
| 2007 | 1.03 Billion USD | 54.81% |
| 2006 | 671.79 Million USD | 33.93% |
| 2005 | 501.58 Million USD | 41.6% |
| 2004 | 354.22 Million USD | 12.46% |
| 2003 | 314.99 Million USD | 243.95% |
| 2002 | 91.58 Million USD | -8.75% |
| 2001 | 100.36 Million USD | -10.73% |
| 2000 | 112.42 Million USD | 226.28% |
| 1999 | 34.45 Million USD | 22.32% |
| 1998 | 28.16 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 15.82 Billion USD | 2.5% |
| 2024 Q2 | 16.64 Billion USD | 5.19% |
| 2024 Q3 | 17.74 Billion USD | 6.57% |
| 2023 Q3 | 14.71 Billion USD | 5.82% |
| 2023 FY | 15.44 Billion USD | 19.02% |
| 2023 Q1 | 13.05 Billion USD | 0.61% |
| 2023 Q2 | 13.9 Billion USD | 6.51% |
| 2023 Q4 | 15.44 Billion USD | 4.95% |
| 2022 Q3 | 13.26 Billion USD | -3.24% |
| 2022 Q2 | 13.7 Billion USD | 0.2% |
| 2022 Q1 | 13.67 Billion USD | 0.91% |
| 2022 FY | 12.97 Billion USD | -4.29% |
| 2022 Q4 | 12.97 Billion USD | -2.16% |
| 2021 Q2 | 12.29 Billion USD | 6.56% |
| 2021 Q3 | 12.93 Billion USD | 5.19% |
| 2021 Q4 | 13.55 Billion USD | 4.8% |
| 2021 FY | 13.55 Billion USD | 21.36% |
| 2021 Q1 | 11.54 Billion USD | 3.33% |
| 2020 Q3 | 10.61 Billion USD | 5.09% |
| 2020 Q1 | 9.89 Billion USD | 1.62% |
| 2020 FY | 11.16 Billion USD | 14.75% |
| 2020 Q2 | 10.1 Billion USD | 2.15% |
| 2020 Q4 | 11.16 Billion USD | 5.19% |
| 2019 Q4 | 9.73 Billion USD | 6.59% |
| 2019 Q2 | 8.53 Billion USD | 3.6% |
| 2019 Q3 | 9.13 Billion USD | 7.03% |
| 2019 Q1 | 8.23 Billion USD | 4.95% |
| 2019 FY | 9.73 Billion USD | 24.04% |
| 2018 Q1 | 6.42 Billion USD | 11.6% |
| 2018 FY | 7.84 Billion USD | 36.27% |
| 2018 Q4 | 7.84 Billion USD | 7.22% |
| 2018 Q3 | 7.31 Billion USD | 6.85% |
| 2018 Q2 | 6.84 Billion USD | 6.59% |
| 2017 FY | 5.75 Billion USD | -11.24% |
| 2017 Q3 | 5.64 Billion USD | 7.5% |
| 2017 Q2 | 5.25 Billion USD | 9.21% |
| 2017 Q1 | 4.8 Billion USD | -25.88% |
| 2017 Q4 | 5.75 Billion USD | 2.01% |
| 2016 Q3 | 6.17 Billion USD | 6.81% |
| 2016 FY | 6.48 Billion USD | 32.19% |
| 2016 Q1 | 5.3 Billion USD | 8.13% |
| 2016 Q4 | 6.48 Billion USD | 5.06% |
| 2016 Q2 | 5.78 Billion USD | 8.94% |
| 2015 Q3 | 4.68 Billion USD | 7.53% |
| 2015 Q1 | 4.12 Billion USD | 4.21% |
| 2015 Q2 | 4.35 Billion USD | 5.53% |
| 2015 Q4 | 4.9 Billion USD | 4.81% |
| 2015 FY | 4.9 Billion USD | 23.94% |
| 2014 Q2 | 3.4 Billion USD | -18.83% |
| 2014 Q1 | 4.19 Billion USD | 6.17% |
| 2014 Q3 | 3.65 Billion USD | 7.25% |
| 2014 Q4 | 3.95 Billion USD | 8.43% |
| 2014 FY | 3.95 Billion USD | 0.23% |
| 2013 Q1 | 4.23 Billion USD | 4.35% |
| 2013 Q4 | 3.95 Billion USD | 6.84% |
| 2013 FY | 3.95 Billion USD | -2.68% |
| 2013 Q2 | 4.2 Billion USD | -0.81% |
| 2013 Q3 | 3.69 Billion USD | -11.99% |
| 2012 FY | 4.05 Billion USD | 32.52% |
| 2012 Q3 | 3.73 Billion USD | 2.93% |
| 2012 Q4 | 4.05 Billion USD | 8.76% |
| 2012 Q1 | 3.33 Billion USD | 8.81% |
| 2012 Q2 | 3.62 Billion USD | 8.8% |
| 2011 FY | 3.06 Billion USD | 28.14% |
| 2011 Q3 | 2.74 Billion USD | 3.63% |
| 2011 Q2 | 2.64 Billion USD | 3.18% |
| 2011 Q1 | 2.56 Billion USD | 7.44% |
| 2011 Q4 | 3.06 Billion USD | 11.55% |
| 2010 Q3 | 2.35 Billion USD | 4.85% |
| 2010 Q2 | 2.24 Billion USD | 11.23% |
| 2010 Q4 | 2.39 Billion USD | 1.64% |
| 2010 Q1 | 2.01 Billion USD | 11.43% |
| 2010 FY | 2.39 Billion USD | 32.09% |
| 2009 FY | 1.8 Billion USD | 22.72% |
| 2009 Q2 | 1.5 Billion USD | 8.31% |
| 2009 Q3 | 1.63 Billion USD | 9.09% |
| 2009 Q4 | 1.8 Billion USD | 10.5% |
| 2009 Q1 | 1.38 Billion USD | -6.01% |
| 2008 Q3 | 1.36 Billion USD | 10.82% |
| 2008 Q1 | 1.12 Billion USD | 8.01% |
| 2008 Q2 | 1.23 Billion USD | 9.62% |
| 2008 Q4 | 1.47 Billion USD | 8.06% |
| 2008 FY | 1.47 Billion USD | 41.79% |
| 2007 Q3 | 912.24 Million USD | 12.8% |
| 2007 Q2 | 808.69 Million USD | 11.67% |
| 2007 Q1 | 724.16 Million USD | 7.8% |
| 2007 Q4 | 1.03 Billion USD | 14.0% |
| 2007 FY | 1.03 Billion USD | 54.81% |
| 2006 Q1 | 524.5 Million USD | 4.57% |
| 2006 FY | 671.79 Million USD | 33.93% |
| 2006 Q4 | 671.79 Million USD | 9.41% |
| 2006 Q3 | 613.99 Million USD | 8.51% |
| 2006 Q2 | 565.83 Million USD | 7.88% |
| 2005 FY | 501.58 Million USD | 41.6% |
| 2005 Q4 | 501.58 Million USD | 17.22% |
| 2005 Q3 | 427.91 Million USD | 9.86% |
| 2005 Q2 | 389.52 Million USD | 5.5% |
| 2005 Q1 | 369.2 Million USD | 4.23% |
| 2004 Q2 | 322.46 Million USD | 1.93% |
| 2004 Q3 | 336.82 Million USD | 4.45% |
| 2004 Q1 | 316.33 Million USD | 0.43% |
| 2004 Q4 | 354.22 Million USD | 5.17% |
| 2004 FY | 354.22 Million USD | 12.46% |
| 2003 FY | 314.99 Million USD | 243.95% |
| 2003 Q4 | 314.99 Million USD | 31.93% |
| 2003 Q3 | 238.76 Million USD | -2.74% |
| 2003 Q2 | 245.48 Million USD | 174.54% |
| 2003 Q1 | 89.41 Million USD | -2.36% |
| 2002 FY | 91.58 Million USD | -8.75% |
| 2002 Q3 | 92.85 Million USD | -0.73% |
| 2002 Q2 | 93.53 Million USD | -2.05% |
| 2002 Q1 | 95.48 Million USD | -4.86% |
| 2002 Q4 | 91.58 Million USD | -1.37% |
| 2001 Q2 | 103 Million USD | -1.91% |
| 2001 Q1 | 105 Million USD | -6.6% |
| 2001 FY | 100.36 Million USD | -10.73% |
| 2001 Q3 | 100.41 Million USD | -2.52% |
| 2001 Q4 | 100.36 Million USD | -0.05% |
| 2000 Q1 | 65.08 Million USD | 0.0% |
| 2000 FY | 112.42 Million USD | 226.28% |
| 2000 Q3 | 111.06 Million USD | 4.22% |
| 2000 Q2 | 106.57 Million USD | 63.75% |
| 2000 Q4 | 112.42 Million USD | 1.22% |
| 1999 FY | 34.45 Million USD | 22.32% |
| 1998 FY | 28.16 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -4061.176% |
| Accuray Incorporated | 468.62 Million USD | -3195.051% |
| Align Technology, Inc. | 6.08 Billion USD | -153.81% |
| Elevance Health Inc. | 108.92 Billion USD | 85.824% |
| AxoGen, Inc. | 196.82 Million USD | -7745.214% |
| Boston Scientific Corporation | 35.13 Billion USD | 56.052% |
| CVS Health Corporation | 249.72 Billion USD | 93.817% |
| Cardinal Health, Inc. | 45.12 Billion USD | 65.778% |
| Centene Corporation | 84.64 Billion USD | 81.756% |
| DaVita Inc. | 17.61 Billion USD | 12.361% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 72.529% |
| Hologic, Inc. | 9.15 Billion USD | -68.649% |
| Humana Inc. | 47.06 Billion USD | 67.191% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -373.677% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | 7.675% |
| Masimo Corporation | 3.04 Billion USD | -407.694% |
| McKesson Corporation | 67.44 Billion USD | 77.104% |
| Patterson Companies, Inc. | 2.96 Billion USD | -420.08% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | -10.123% |
| ResMed Inc. | 6.87 Billion USD | -124.689% |
| Henry Schein, Inc. | 10.57 Billion USD | -46.047% |
| Teladoc Health, Inc. | 4.39 Billion USD | -251.553% |
| Universal Health Services, Inc. | 14.35 Billion USD | -7.555% |
| Veeva Systems Inc. | 5.91 Billion USD | -161.237% |
| Baxter International Inc. | 28.27 Billion USD | 45.39% |
| Becton, Dickinson and Company | 52.78 Billion USD | 70.744% |
| Danaher Corporation | 84.48 Billion USD | 81.723% |
| Stryker Corporation | 39.91 Billion USD | 61.311% |
| Medtronic plc | 89.98 Billion USD | 82.839% |